리가켐바이오

141080 코스닥
176,600 2,000 (-1.12%)
기준 : 02/13
  • 시가총액
    64,654억
  • 주식수
    3,661만
  • PER
    -257.29배
  • PBR
    11.67배
  • ROE
    -4.54%
  • 결산월
    12월

25.4Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09
매출액(수익) 1,4151,415.5 1,5921,592.7 1,4821,482.8 1,4641,464.1 1,2581,258.9
내수 N/AN/A 160160.6 208208.1 208208.6 205205.3
수출 N/AN/A 1,0171,017.9 1,2741,274.6 1,2551,255.5 1,0531,053.6
기타 N/AN/A 1,5921,592.7 00.0 00.0 00.0
매출원가 N/AN/A 161161.2 160160.1 161161.5 159159.5
원재료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재고자산의변동 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타원가 N/AN/A 00.1 00.4 -80-80.8 -80-80.6
인건비 N/AN/A 271271.8 275275.1 325325.1 322322.8
감가상각비 N/AN/A 3131.0 3131.0 3535.5 3535.5
기타 N/AN/A -141-141.8 -146-146.5 -118-118.2 -118-118.2
매출총이익 N/AN/A 1,4311,431.4 1,3221,322.6 1,3021,302.6 1,0991,099.4
판매비와관리비 N/AN/A 1,9021,902.1 1,5561,556.2 1,4261,426.6 1,3081,308.6
급여 N/AN/A 5252.8 5757.1 5050.4 4747.1
퇴직급여 N/AN/A 66.7 66.4 66.1 88.7
복리후생비 N/AN/A 55.0 44.8 44.4 44.2
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 7878.5 7575.3 7171.7 6868.9
용역비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 1,7511,751.9 1,4021,402.7 1,2661,266.1 1,1311,131.8
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -49-49.2 -46-46.3 -53-53.1 -33-33.8
감가상각비 N/AN/A 44.6 44.8 44.7 44.4
무형자산상각비 N/AN/A 1515.0 1414.9 1414.7 1414.6
기타 N/AN/A 3636.6 3636.2 6161.3 6262.4
영업이익 -1,064-1,064.8 -470-470.7 -233-233.5 -123-123.9 -209-209.1
EBITDA N/AN/A -455-455.8 -206-206.2 8181.7 -53-53.3
금융손익 N/AN/A 144144.4 175175.6 371371.6 291291.1
금융수익 N/AN/A 289289.3 333333.5 424424.9 342342.0
이자수익 N/AN/A 198198.7 216216.1 231231.6 199199.7
외환거래이익 N/AN/A 5656.0 4646.8 4949.8 6868.0
외환차익 N/AN/A 2727.8 2424.4 1818.4 4343.2
외화환산이익 N/AN/A 2828.2 2222.3 3131.4 2424.8
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A 00.2 00.0 N/AN/A N/AN/A
금융자산평가이익 N/AN/A 1515.6 5151.8 115115.5 4646.4
파생상품이익 N/AN/A 1818.7 1818.7 2727.8 2727.8
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 144144.9 157157.8 5353.3 5050.9
이자비용 N/AN/A 11.8 44.3 33.6 55.0
외환거래손실 N/AN/A 6868.2 9696.8 2525.1 2121.5
외환차손 N/AN/A 5454.3 4242.9 2323.1 1818.5
외화환산손실 N/AN/A 1313.9 5353.8 22.0 22.9
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A 5050.4 5050.4 N/AN/A N/AN/A
금융자산평가손실 N/AN/A 00.6 -17-17.5 00.6 00.6
파생상품손실 N/AN/A 2323.8 2323.8 2323.8 2323.8
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A 11.2 11.9 00.8 00.8
기타영업외수익 N/AN/A 22.2 22.5 11.5 11.5
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 00.0 00.0 00.0 00.1
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A 00.7 00.7 00.7 00.7
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 11.5 11.8 00.8 00.7
기타영업외비용 N/AN/A 11.0 00.6 00.6 00.7
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 00.6 00.2 00.3 00.3
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 00.0 00.0 00.0 00.0
무형자산처분손실 N/AN/A 00.0 00.0 00.0 N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A 00.3 00.3 00.3 00.3
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 00.0 00.0 00.0
종속기업및관계기업관련손익 N/AN/A 88.4 66.7 1010.1 88.4
지분법손익 N/AN/A 88.4 66.7 1010.1 88.4
지분법이익 N/AN/A 88.4 66.7 1010.1 88.4
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A -316-316.5 -49-49.1 258258.7 9191.2
법인세비용 N/AN/A 77.1 88.6 1010.1 1313.2
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 -915-915.5 -323-323.6 -57-57.8 248248.5 7878.0
지배지분 순이익 N/AN/A -251-251.2 1717.5 248248.5 7878.0
비지배지분 순이익 N/AN/A -72-72.4 -75-75.3 N/AN/A N/AN/A
기타포괄이익 N/AN/A 130130.6 134134.4 -5-5.9 -13-13.2
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A 00.0 00.0 00.0 00.0
해외사업환산손익 N/AN/A 1616.7 2424.9 1111.4 44.5
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 113113.8 109109.5 -17-17.4 -17-17.7
총포괄이익 N/AN/A -193-193.0 7676.6 242242.6 6464.7
지배지분 총포괄이익 N/AN/A -130-130.8 142142.2 242242.6 6464.7
비지배지분 총포괄이익 N/AN/A -62-62.2 -65-65.5 N/AN/A N/AN/A
주당순이익 N/AN/A -686-686.3 4848.2 678678.7 283283.9
시가총액 N/AN/A 51,43751,437.5 42,02842,028.6 34,74334,743.2 39,90539,905.2
주가 N/AN/A 140,500140,500.0 114,800114,800.0 94,90094,900.0 109,000109,000.0
주가수익배수 N/AN/A -204.70-204.70 2399.392399.39 139.76139.76 511.60511.60
주식수(만주) N/A 3,661 3,661 3,661 3,661 3,657 3,657 3,608 2,812 2,649 2,649 2,641 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 2,144 2,120 2,120 2,120 2,118 2,118 2,118 2,118 1,991 1,991 1,991 1,988 1,988 1,986

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄